The Racing Medication and Testing Consortium (RMTC) will, among other things, discuss proposals to phase out race-day medication use during its next meeting Aug. 4.

The RMTC, a group of 25 industry stakeholders, said earlier it would meet to follow up on information gleaned from an international race-day medication summit held at Belmont Park in Elmont, N.Y. in June.

Soon after the summit the RMTC formed committees to focus on the phase-out of race-day drugs, penalty guidelines for medication violations, stable area security and surveillance, and guidelines for the administration of permitted race-day medications. The RMTC said the committees are made up of "a cross-section of industry stakeholders, including horsemen, industry executives, racetrack operators, and directors of racing, regulators, and veterinarians."

The Aug. 4 meeting, to be held in the Cincinnati, Ohio, metropolitan area, will come less than two weeks before The Jockey Club Round Table meeting in Saratoga Springs, N.Y., on Aug. 14. A report on the future of the Thoroughbred racing industry will be discussed at that meeting